JP2025514275A5 - - Google Patents
Info
- Publication number
- JP2025514275A5 JP2025514275A5 JP2024563502A JP2024563502A JP2025514275A5 JP 2025514275 A5 JP2025514275 A5 JP 2025514275A5 JP 2024563502 A JP2024563502 A JP 2024563502A JP 2024563502 A JP2024563502 A JP 2024563502A JP 2025514275 A5 JP2025514275 A5 JP 2025514275A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2206353.1A GB202206353D0 (en) | 2022-04-29 | 2022-04-29 | Treatment of cervical dystonia |
| GB2206353.1 | 2022-04-29 | ||
| PCT/GB2023/050742 WO2023209326A1 (en) | 2022-04-29 | 2023-03-23 | Treatment of cervical dystonia |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025514275A JP2025514275A (ja) | 2025-05-02 |
| JPWO2023209326A5 JPWO2023209326A5 (https=) | 2026-03-31 |
| JP2025514275A5 true JP2025514275A5 (https=) | 2026-03-31 |
Family
ID=81943814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024563502A Pending JP2025514275A (ja) | 2022-04-29 | 2023-03-23 | 頸部ジストニアの治療 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250302928A1 (https=) |
| EP (1) | EP4514378A1 (https=) |
| JP (1) | JP2025514275A (https=) |
| KR (1) | KR20250004869A (https=) |
| CN (1) | CN119110728A (https=) |
| AU (1) | AU2023262641A1 (https=) |
| CA (1) | CA3245899A1 (https=) |
| GB (1) | GB202206353D0 (https=) |
| WO (1) | WO2023209326A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025231403A1 (en) * | 2024-05-03 | 2025-11-06 | Revivity Pharma Corporation | Methods of administering and manufacturing toxic compounds |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| IL99552A0 (en) | 1990-09-28 | 1992-08-18 | Ixsys Inc | Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof |
| DE102004043009A1 (de) | 2004-09-06 | 2006-03-23 | Toxogen Gmbh | Transportprotein zum Einbringen chemischer Verbindungen in Nervenzellen |
| DE102005019302A1 (de) | 2005-04-26 | 2006-11-16 | Toxogen Gmbh | Carrier zum Targeting von Nervenzellen |
| ES2369558T3 (es) | 2005-09-19 | 2011-12-01 | Allergan, Inc. | Toxinas clostridiales y toxinas clostridiales activables. |
| CA2758274C (en) | 2009-04-14 | 2018-04-10 | Mcw Research Foundation, Inc. | Engineered botulinum neurotoxin |
| US8853360B2 (en) | 2010-06-23 | 2014-10-07 | Wisconsin Alumni Research Foundation | Engineered botulinum neurotoxin C1 with selective substrate specificity |
| EP3162894B1 (en) | 2011-05-19 | 2024-01-10 | Ipsen Bioinnovation Limited | Methods for the manufacture of proteolytically processed polypeptides |
| SG10201606666XA (en) | 2012-05-30 | 2016-09-29 | Harvard College | Engineered Botulinum Neurotoxin |
| WO2014079495A1 (en) | 2012-11-21 | 2014-05-30 | Syntaxin Limited | Methods for the manufacture of proteolytically processed polypeptides |
| GB201312317D0 (en) | 2013-07-09 | 2013-08-21 | Syntaxin Ltd | Cationic neurotoxins |
| PT3274364T (pt) | 2015-03-26 | 2021-11-05 | Harvard College | Neurotoxina botulínica manipulada |
| GB201607901D0 (en) | 2016-05-05 | 2016-06-22 | Ipsen Biopharm Ltd | Chimeric neurotoxins |
| EP3481852B1 (en) | 2016-07-08 | 2022-12-07 | Children's Medical Center Corporation | A novel botulinum neurotoxin and its derivatives |
| TWI810228B (zh) * | 2017-12-20 | 2023-08-01 | 英商艾普森生物製藥有限公司 | 自主神經系統障礙之治療 |
| JP2024534384A (ja) * | 2021-09-16 | 2024-09-20 | イプセン バイオファーム リミテッド | 頸部ジストニアを治療する用途の修飾ＢｏＮＴ／Ａ |
-
2022
- 2022-04-29 GB GBGB2206353.1A patent/GB202206353D0/en not_active Ceased
-
2023
- 2023-03-23 US US18/851,566 patent/US20250302928A1/en active Pending
- 2023-03-23 KR KR1020247039344A patent/KR20250004869A/ko active Pending
- 2023-03-23 WO PCT/GB2023/050742 patent/WO2023209326A1/en not_active Ceased
- 2023-03-23 EP EP23715221.0A patent/EP4514378A1/en active Pending
- 2023-03-23 JP JP2024563502A patent/JP2025514275A/ja active Pending
- 2023-03-23 CA CA3245899A patent/CA3245899A1/en active Pending
- 2023-03-23 CN CN202380036879.2A patent/CN119110728A/zh active Pending
- 2023-03-23 AU AU2023262641A patent/AU2023262641A1/en active Pending